Cargando…
use disorder in patients with autoimmune diseases:sociodemographic profile
INTRODUCTION: Autoimmune diseases are chronic and disabling conditions, especially because of the chronic pain they cause. Substance use disorders are on the rise in these patients, especially the problematic use of prescribed and over-the-counter analgesics. OBJECTIVES: to study the socio-demograph...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478962/ http://dx.doi.org/10.1192/j.eurpsy.2023.1611 |
_version_ | 1785101463427481600 |
---|---|
author | Stati, S. |
author_facet | Stati, S. |
author_sort | Stati, S. |
collection | PubMed |
description | INTRODUCTION: Autoimmune diseases are chronic and disabling conditions, especially because of the chronic pain they cause. Substance use disorders are on the rise in these patients, especially the problematic use of prescribed and over-the-counter analgesics. OBJECTIVES: to study the socio-demographic profile of patients with comorbidity between substance use disorders and autoimmune diseases, to assess the reasons for admission, the length of hospitalization, and the main psychoactive substances found in these patients METHODS: A retrospective cross-sectional study of the medical records of patients with substance use disorders co-morbid with autoimmune diseases who were hospitalized in the addictology department of the ar-Razi University Psychiatric Hospital in Salé between January 2014 and December 2021. RESULTS: 10 patients were included in our study, the median age was 42, 76% were male, 41.3% were single, 63% had an average socio-economic level. 43.5% of the patients had a medical history, the main reason for admission was depressive syndrome (50%), the most common autoimmune disease was insulin-dependent diabetes, followed by IBD CONCLUSIONS: the comorbidity of autoimmune diseases and substance use disorders suggests the existence of common etiopathogenic mechanisms, the management of this comorbidity requires multidisciplinary collaboration DISCLOSURE OF INTEREST: None Declared |
format | Online Article Text |
id | pubmed-10478962 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-104789622023-09-06 use disorder in patients with autoimmune diseases:sociodemographic profile Stati, S. Eur Psychiatry Abstract INTRODUCTION: Autoimmune diseases are chronic and disabling conditions, especially because of the chronic pain they cause. Substance use disorders are on the rise in these patients, especially the problematic use of prescribed and over-the-counter analgesics. OBJECTIVES: to study the socio-demographic profile of patients with comorbidity between substance use disorders and autoimmune diseases, to assess the reasons for admission, the length of hospitalization, and the main psychoactive substances found in these patients METHODS: A retrospective cross-sectional study of the medical records of patients with substance use disorders co-morbid with autoimmune diseases who were hospitalized in the addictology department of the ar-Razi University Psychiatric Hospital in Salé between January 2014 and December 2021. RESULTS: 10 patients were included in our study, the median age was 42, 76% were male, 41.3% were single, 63% had an average socio-economic level. 43.5% of the patients had a medical history, the main reason for admission was depressive syndrome (50%), the most common autoimmune disease was insulin-dependent diabetes, followed by IBD CONCLUSIONS: the comorbidity of autoimmune diseases and substance use disorders suggests the existence of common etiopathogenic mechanisms, the management of this comorbidity requires multidisciplinary collaboration DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10478962/ http://dx.doi.org/10.1192/j.eurpsy.2023.1611 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Stati, S. use disorder in patients with autoimmune diseases:sociodemographic profile |
title | use disorder in patients with autoimmune diseases:sociodemographic profile |
title_full | use disorder in patients with autoimmune diseases:sociodemographic profile |
title_fullStr | use disorder in patients with autoimmune diseases:sociodemographic profile |
title_full_unstemmed | use disorder in patients with autoimmune diseases:sociodemographic profile |
title_short | use disorder in patients with autoimmune diseases:sociodemographic profile |
title_sort | use disorder in patients with autoimmune diseases:sociodemographic profile |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10478962/ http://dx.doi.org/10.1192/j.eurpsy.2023.1611 |
work_keys_str_mv | AT statis usedisorderinpatientswithautoimmunediseasessociodemographicprofile |